MySugr
Specializes in app-based, all-around care for people with diabetes made by people with diabetes.
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 24 % | 8 % | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
mySugr is a digital health company specializing in diabetes management solutions. The company offers a mobile app designed to simplify the lives of people with diabetes by providing tools for tracking blood sugar levels, calculating insulin doses, and logging meals. The app integrates seamlessly with Accu-Chek devices, allowing users to sync their data for a comprehensive overview of their health metrics. mySugr serves individuals with diabetes, primarily targeting those who require regular insulin management. Operating in the digital health market, mySugr employs a freemium business model, offering basic features for free while charging for premium services like advanced reporting and personalized support. Revenue is generated through subscription fees and partnerships with healthcare providers and device manufacturers. The app is available on both Android and iOS platforms, making it accessible to a wide audience. Key features include a bolus calculator, smart logs, multi-device syncing, and estimated HbA1c tracking. The company aims to reduce the burden of diabetes management through user-friendly and intuitive digital solutions.
Keywords: diabetes management, bolus calculator, device syncing, personalized logging, insulin calculations, digital health, freemium model, Accu-Chek integration, HbA1c tracking, mobile app.